NCT07170774

Brief Summary

The purpose of this clinical trial is to investigate whether IPC can improve aerobic capacity during exercise. The primary question it aims to answer is: Does IPC enhance the aerobic capacity of athletes? The researchers will compare IPC (220 mmHg pressure) with a placebo (20 mmHg pressure) to see if different interventions can enhance aerobic capacity and exercise performance. Participants will:

  • Undergo a randomized crossover controlled trial, visiting twice, with a one-week interval between each test.
  • Conduct two assessments at the testing site each time, namely a pre-intervention assessment and a post-intervention assessment.
  • Record their heart rate, blood pressure, weight, oxygen uptake, Taekwondo-specific performance, and other indicators.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

September 7, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 12, 2025

Completed
Last Updated

September 12, 2025

Status Verified

September 1, 2025

Enrollment Period

2 months

First QC Date

September 7, 2025

Last Update Submit

September 11, 2025

Conditions

Keywords

Ischemic preconditioningEnergy metabolismSports performanceOxygen uptake

Outcome Measures

Primary Outcomes (3)

  • Oxygen uptake

    To record the oxygen uptake of the subjects and compare the changes in oxygen uptake after the intervention.

    Participants had their oxygen uptake measured continuously during both visits, extending until six minutes after the completion of the exercise test.

  • Taekwondo-specific sports performance test

    The specialized athletic ability in Taekwondo is measured by the number of kicks performed during the test.

    The subjects rested quietly for five minutes before baseline measurements were taken. After this, the collection of metabolic gases commenced. Throughout the experiment, metabolic gases were continuously collected until six minutes after the tests.

  • Blood lactate

    Used to measure the intensity and metabolic adaptations during the testing process of taekwondo athletes

    Blood lactate levels were measured at baseline, immediately after the intervention at 3 minutes, and at 3 and 10 minutes post-testing.

Study Arms (2)

IPC Trial

EXPERIMENTAL

220 mmHg

Device: Ischemic Preconditioning

SHAM Trial

PLACEBO COMPARATOR

20 mmHg

Device: Sham

Interventions

Compression cuff width: 10CM; Compression duration: 5min/5min (ischemia/reperfusion) \*4. 220 mmHg

IPC Trial
ShamDEVICE

Compression cuff width: 10CM; Compression duration: 5min/5min (compression/relaxation) \*4. 20 mmHg

SHAM Trial

Eligibility Criteria

Age18 Years - 22 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • adult male athletes aged 18 years or older;
  • taekwondo athletes classified as national second-class or above (having placed in the top three provincial professional taekwondo championships or the top eight national professional taekwondo championships);
  • consistent and unified training over the past three months;
  • no prior ischemic preconditioning;
  • competitive taekwondo athletes.

You may not qualify if:

  • supplementation with creatine;
  • acute or chronic illnesses, including anxiety, depression, cardiovascular diseases, and metabolic disorders;
  • engaging in vigorous physical activity within 48 hours prior to the experiment;
  • consuming alcohol or caffeine within 24 hours before the experiment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangzhou Sport University

Guangzhou, 510500, China

Location

Related Publications (4)

  • Cheng CF, Kuo YH, Hsu WC, Chen C, Pan CH. Local and Remote Ischemic Preconditioning Improves Sprint Interval Exercise Performance in Team Sport Athletes. Int J Environ Res Public Health. 2021 Oct 12;18(20):10653. doi: 10.3390/ijerph182010653.

    PMID: 34682399BACKGROUND
  • Chen Y, Yang J, Muradov O, Li X, Lee JKW, Qiu J. Effect of ischemic preconditioning on maximum accumulated oxygen deficit in 400-meter runners. Eur J Sport Sci. 2023 May;23(5):789-796. doi: 10.1080/17461391.2022.2064769. Epub 2022 Apr 25.

    PMID: 35400298BACKGROUND
  • Caru M, Levesque A, Lalonde F, Curnier D. An overview of ischemic preconditioning in exercise performance: A systematic review. J Sport Health Sci. 2019 Jul;8(4):355-369. doi: 10.1016/j.jshs.2019.01.008. Epub 2019 Jan 23.

    PMID: 31333890BACKGROUND
  • Albuquerque MR, Flor CAG, Ribeiro AIS, Mesquita PHC, Franchini E, Laurentino GC. Effects of Ischemic Preconditioning on Sport-Specific Performance in Highly Trained Taekwondo Athletes. Sports (Basel). 2024 Jun 26;12(7):179. doi: 10.3390/sports12070179.

    PMID: 39058070BACKGROUND

MeSH Terms

Interventions

Ischemic Preconditioning

Intervention Hierarchy (Ancestors)

TherapeuticsInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Sponsor-Investigator

Study Record Dates

First Submitted

September 7, 2025

First Posted

September 12, 2025

Study Start

April 1, 2024

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

September 12, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

The data presented in this study are currently unpublished. The corresponding author will provide the relevant research data upon reasonable request after the associated paper has been officially accepted.

Locations